Businesses Winning Women’s Hearts to Thrive: 9 Mega Trends Leading the Way in the Sheconomy


The increasing economic power of women worldwide encourages investors across sectors to adopt a growth strategy that focuses on women as consumers, finds Frost & Sullivan’s recent analysis, Nine Mega Trends Leading the Sheconomy. Women’s shift in consumption and spending patterns with the rise in their income will create immense potential for online retail, large-format convenience stores, and doorstep services. Also, global female income is expected to reach $29.3 trillion annually by 2026, up from $23.2 trillion in 2020.

For further information on this analysis, please click here.

“In the next five years, female consumer spending will grow significantly, creating opportunities across sectors. As more women rise in corporate or business, they will need efficient financial services that cater exclusively to their needs,” said Vinay Venkatesan, Global Research Manager for TechVision at Frost & Sullivan. “This trend in the Sheconomy will compel industries such as retail, finance, and automotive to deploy artificial intelligence (AI)-enabled services to cater to the unique needs of growing women professionals.”

Venkatesan added: “As 80 million more women are expected to join the global labor force by 2030, females on company boards will create a new wave of both corporate and retail consumers. Additionally, organizations need to have women-oriented business models to target them as professionals and customers.”

To tap into the female-powered economic growth prospects:

  • Financial organizations should invest in developing a women-oriented bank that offers financial solutions and client support to help make the right financial decisions.
  • Companies need to collaborate with start-ups to design personalized digital health solutions for female health issues, focusing on information, diagnoses, and treatments.
  • Retailers should integrate gender intelligence to create a shopping environment that’s more appealing to female consumers.

Nine Mega Trends Leading the Sheconomy is the latest addition to Frost & Sullivan’s TechVision research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.


Respiratory Health Management Market to Expedite Digital, Smart, and Portable Solutions


The COVID-19 outbreak has inflated the demand for smart and digitally connected medical devices such as artificial intelligence (AI)-based mobile medical applications and medical imaging software, ensuring better management of severe respiratory diseases. Innovative medical devices such as mobile medical applications and inhalers are the mainstay of the respiratory disease management industry. However, the high costs of devices, heavy competition, absence of real-time feedback, and lack of awareness among patients have restricted the adoption of such technologies.

For further information on this analysis, Respiratory Health Management Technology Growth Opportunities, please visit:

“The respiratory health market is focusing on technology convergence; integrating digital and sensor technologies to create smart, portable, and connected medical devices; and improving clinical outcomes and patient engagement during the disease management process,” said Ashish Kaul, Senior Research Analyst, TechVision, at Frost & Sullivan.

Kaul added: “Mobile medical applications for the diagnosis and management of respiratory diseases can reduce the cost of medical care by eliminating the need for regular medical tests. Further, smart medical devices such as inhalers that offer personalized insights and care anywhere are expected to increase the adoption of a home-based disease management regime in the next one to two years, as it follows the current trend of remote care.”

As mobile medical applications, oxygen concentrators, and smart inhalers are experiencing significant innovations fueled by the COVID-19 pandemic, market participants can focus on the following to tap into these growth opportunities:

  • Smart inhaler capable of providing feedback and support: Pharmaceutical companies can collaborate or partner with innovative start-ups that offer real-time feedback on the inhaler technique and use acoustic technology for drug delivery to the patients.
  • Innovative and durable oxygen concentrators: Health technology companies and innovators can partner to explore opportunities to produce improved, durable, and easy-to-operate oxygen concentrators for hospital and home purposes.
  • Innovative mobile medical applications: Innovators should invest in research-based evidence to showcase the effectiveness of mobile medical applications in the improved management of respiratory diseases.

Respiratory Health Management Technology Growth Opportunities is the latest addition to Frost & Sullivan’s Healthcare research and analyses available through the Frost & Sullivan Leadership Council, which helps organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future.